Labtician Théa

Labtician Théa is a specialized ophthalmic company based in Canada, established as a joint venture between the Canadian firm Labtician Ophthalmics and the French global leader Laboratoires Théa. The company focuses on providing innovative, preservative-free treatments for a wide range of eye conditions, including glaucoma, dry eye, and ocular surface diseases. Their portfolio includes well-known brands such as Monoprost and Thealoz Duo, alongside a suite of surgical instruments and diagnostic tools. By combining international R&D with local market expertise, Labtician Théa serves as a comprehensive partner for eye care professionals across Canada. The company is committed to improving patient outcomes through advanced therapeutic options and educational support. Their operations encompass both pharmaceutical distribution and medical device sales within the Canadian healthcare landscape.